Phase 3
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere’s Disease
https://clinicaltrials.gov/ct2/show/NCT03664674
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere’s Disease
Previous update: October 10, 2019
Recent update: March 6, 2020
Updated on June 17, 2020 – new study location(s) added
Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere’s Disease Outcomes
https://clinicaltrials.gov/ct2/show/NCT04218123?type=Intr&cond=Meniere+Disease&lupd_s=12%2F23%2F2019&lupd_d=14
Condition : Meniere Disease
Interventions : Drug: Venlafaxine; Drug: Placebo oral tablet
Sponsors : Medical University of South Carolina; American Hearing Research Foundation
Not yet recruiting
Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere’s Disease Outcomes
NCT04218123
Mon, 06 Jan 2020 12:00:00 EST
